Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept study

BACKGROUND: Treatment of patients diagnosed with angina due to epicardial or microvascular coronary artery spasm (CAS) is challenging because patients often remain symptomatic despite conventional pharmacological therapy. In this prospective, randomized, double-blind, placebo-controlled, sequential...

Descripción completa

Detalles Bibliográficos
Autores principales: Feenstra, Rutger G.T., Jansen, Tijn P.J., Matthijs Boekholdt, S., Brouwer, Janet E., Klees, Margriet I., Appelman, Yolande, Wittekoek, Marianne E., van de Hoef, Tim P., de Winter, Robbert J., Piek, Jan J., Damman, Peter, Beijk, Marcel A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422675/
https://www.ncbi.nlm.nih.gov/pubmed/37576078
http://dx.doi.org/10.1016/j.ijcha.2023.101238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422675/
https://www.ncbi.nlm.nih.gov/pubmed/37576078
http://dx.doi.org/10.1016/j.ijcha.2023.101238

Ejemplares similares